# EMROSI
> **NDA219015** · New Drug Application · Sponsor: JOURNEY · Approved 2024-11-01
## Drug
- **FDA Application Number:** NDA219015
- **Application type:** New Drug Application
- **Brand name:** EMROSI
- **Generic name:** MINOCYCLINE HYDROCHLORIDE EXTENDED-RELEASE
- **Active ingredients:** MINOCYCLINE HYDROCHLORIDE
- **Dosage form:** CAPSULE, EXTENDED RELEASE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** JOURNEY
- **Manufacturer:** Journey Medical Corporation
- **First approval:** 2024-11-01
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=219015)
---
*MORVS · CC0 1.0*